IL163625A0 - Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same - Google Patents
Alkoxy-pyridine derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL163625A0 IL163625A0 IL16362503A IL16362503A IL163625A0 IL 163625 A0 IL163625 A0 IL 163625A0 IL 16362503 A IL16362503 A IL 16362503A IL 16362503 A IL16362503 A IL 16362503A IL 163625 A0 IL163625 A0 IL 163625A0
- Authority
- IL
- Israel
- Prior art keywords
- alkoxy
- same
- pharmaceutical compositions
- compositions containing
- pyridine derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 3H-imidazo[4,5-b]pyridin-2-yl Chemical group 0.000 abstract 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 abstract 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02007049 | 2002-03-27 | ||
PCT/EP2003/003076 WO2003080607A1 (en) | 2002-03-27 | 2003-03-25 | Novel alkoxypyridine-derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
IL163625A0 true IL163625A0 (en) | 2005-12-18 |
Family
ID=28051741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16362503A IL163625A0 (en) | 2002-03-27 | 2003-03-25 | Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same |
Country Status (19)
Country | Link |
---|---|
US (1) | US7138399B2 (no) |
EP (1) | EP1490366B1 (no) |
JP (1) | JP4448695B2 (no) |
KR (1) | KR20050002910A (no) |
CN (1) | CN1307176C (no) |
AT (1) | ATE384722T1 (no) |
AU (1) | AU2003226706A1 (no) |
BR (1) | BR0308785A (no) |
CA (1) | CA2480385A1 (no) |
DE (1) | DE60318826T2 (no) |
ES (1) | ES2300599T3 (no) |
HK (1) | HK1078850A1 (no) |
IL (1) | IL163625A0 (no) |
MX (1) | MXPA04009283A (no) |
NO (1) | NO20044633L (no) |
NZ (1) | NZ535959A (no) |
PL (1) | PL372409A1 (no) |
WO (1) | WO2003080607A1 (no) |
ZA (1) | ZA200407766B (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06003349A (es) * | 2003-10-01 | 2006-06-08 | Altana Pharma Ag | Derivados de imidazopiridina como inhibidores de no-sintasa inducible. |
BRPI0414873A (pt) * | 2003-10-01 | 2006-12-12 | Altana Pharma Ag | derivados de imidazopiridina como inibidores de no-sintase induzìveis |
WO2005030770A1 (en) * | 2003-10-01 | 2005-04-07 | Altana Pharma Ag | Imidazopyridine-derivatives as inducible no-synthase inhibitors |
JP2007507463A (ja) * | 2003-10-01 | 2007-03-29 | アルタナ ファルマ アクチエンゲゼルシャフト | 誘導性NOシンターゼ阻害剤としてのイミダゾ[4,5−b]ピリジン誘導体 |
BRPI0415034A (pt) * | 2003-10-01 | 2006-12-12 | Altana Pharma Ag | derivados de aminopiridina como inibidores de não-sintase induzìveis |
WO2005063732A1 (en) * | 2003-12-23 | 2005-07-14 | Microbia, Inc. | Compounds and methods for the treatment of asthma |
ATE400319T1 (de) | 2004-05-28 | 2008-07-15 | Nycomed Gmbh | Tetrahydropyridothiophene |
AU2005251485A1 (en) | 2004-06-11 | 2005-12-22 | 4Sc Ag | Tetrahydropyridothiophenes for treating hyperproliferative disorders |
JP2008529989A (ja) | 2005-02-09 | 2008-08-07 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌のような増殖性の疾病の治療用のテトラヒドロピリドチオフェン |
US7741488B2 (en) | 2005-02-11 | 2010-06-22 | 4Sc Ag | Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer |
CA2602284A1 (en) | 2005-03-31 | 2006-10-05 | Nycomed Gmbh | Imidazopyridine derivatives useful as inos inhibitors |
EP1893618A2 (en) | 2005-05-25 | 2008-03-05 | Nycomed GmbH | Tetrahydropyridothiophenes for use in the treatment of cancer |
AU2006251167A1 (en) | 2005-05-25 | 2006-11-30 | 4Sc Ag | Tetrahydropyridothiophenes for use in the treatment of cancer |
UY29825A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones |
UY29823A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones |
WO2008031788A1 (en) * | 2006-09-12 | 2008-03-20 | Nycomed Gmbh | Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase |
US20080139608A1 (en) * | 2006-12-06 | 2008-06-12 | Universiteit Leiden | 2,6,8, Trisubstituted 1-deazapurines and their different uses |
CA2826649C (en) * | 2011-02-25 | 2016-07-26 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
KR20140040801A (ko) * | 2011-07-15 | 2014-04-03 | 시오노기세야쿠 가부시키가이샤 | Ampk 활성화 작용을 갖는 아자벤즈이미다졸 유도체 |
GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418966B (sv) * | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
GB8307865D0 (en) | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
SE512835C2 (sv) | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
-
2003
- 2003-03-25 PL PL03372409A patent/PL372409A1/xx not_active Application Discontinuation
- 2003-03-25 US US10/509,396 patent/US7138399B2/en not_active Expired - Fee Related
- 2003-03-25 IL IL16362503A patent/IL163625A0/xx unknown
- 2003-03-25 JP JP2003578361A patent/JP4448695B2/ja not_active Expired - Fee Related
- 2003-03-25 AT AT03744851T patent/ATE384722T1/de not_active IP Right Cessation
- 2003-03-25 ES ES03744851T patent/ES2300599T3/es not_active Expired - Lifetime
- 2003-03-25 WO PCT/EP2003/003076 patent/WO2003080607A1/en active IP Right Grant
- 2003-03-25 CA CA002480385A patent/CA2480385A1/en not_active Abandoned
- 2003-03-25 DE DE60318826T patent/DE60318826T2/de not_active Expired - Lifetime
- 2003-03-25 CN CNB038069172A patent/CN1307176C/zh not_active Expired - Fee Related
- 2003-03-25 BR BR0308785-9A patent/BR0308785A/pt not_active IP Right Cessation
- 2003-03-25 MX MXPA04009283A patent/MXPA04009283A/es active IP Right Grant
- 2003-03-25 AU AU2003226706A patent/AU2003226706A1/en not_active Abandoned
- 2003-03-25 KR KR10-2004-7015438A patent/KR20050002910A/ko not_active Application Discontinuation
- 2003-03-25 NZ NZ535959A patent/NZ535959A/en not_active IP Right Cessation
- 2003-03-25 EP EP03744851A patent/EP1490366B1/en not_active Expired - Lifetime
-
2004
- 2004-09-27 ZA ZA200407766A patent/ZA200407766B/en unknown
- 2004-10-27 NO NO20044633A patent/NO20044633L/no not_active Application Discontinuation
-
2005
- 2005-11-23 HK HK05110611A patent/HK1078850A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2005525388A (ja) | 2005-08-25 |
US7138399B2 (en) | 2006-11-21 |
BR0308785A (pt) | 2005-01-11 |
ATE384722T1 (de) | 2008-02-15 |
US20050171125A1 (en) | 2005-08-04 |
DE60318826T2 (de) | 2009-01-22 |
CN1307176C (zh) | 2007-03-28 |
ZA200407766B (en) | 2006-06-28 |
NZ535959A (en) | 2006-05-26 |
PL372409A1 (en) | 2005-07-25 |
CA2480385A1 (en) | 2003-10-02 |
HK1078850A1 (en) | 2006-03-24 |
MXPA04009283A (es) | 2005-01-25 |
AU2003226706A1 (en) | 2003-10-08 |
KR20050002910A (ko) | 2005-01-10 |
ES2300599T3 (es) | 2008-06-16 |
EP1490366A1 (en) | 2004-12-29 |
EP1490366B1 (en) | 2008-01-23 |
JP4448695B2 (ja) | 2010-04-14 |
DE60318826D1 (de) | 2008-03-13 |
CN1642955A (zh) | 2005-07-20 |
WO2003080607A1 (en) | 2003-10-02 |
NO20044633L (no) | 2004-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1078850A1 (en) | Novel alkoxypyridine-derivatives | |
IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
ATE301653T1 (de) | Pyrazolopyridine | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
HK1053834A1 (zh) | 用作nos抑制劑的n-雜環衍生物 | |
AU2002246728A1 (en) | Carboline derivatives | |
AU7779900A (en) | Trifluoromethyl-substituted spirocyclic ketoenols | |
ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
UA83091C2 (en) | Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors | |
MY126917A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
AU2002249890A1 (en) | Carboline derivatives | |
AU2002239348A1 (en) | Pyrazolopyridine derivatives | |
NO984470L (no) | Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase | |
IL173895A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
IL151198A0 (en) | Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same | |
IL173629A0 (en) | Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same | |
AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
MXPA03001356A (es) | Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos. | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla | |
CA2309485A1 (en) | New 4-arylpiperidine derivatives for the treatment of pruritus |